Molecules, Vol. 23, Pages 1929: In Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [11C]Celecoxib, a COX-2 PET Ligand, in Nonhuman Primates
Molecules, Vol. 23, Pages 1929: In Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [11C]Celecoxib, a COX-2 PET Ligand, in Nonhuman Primates
Molecules doi: 10.3390/molecules23081929
Authors:
J. S. Dileep Kumar
Bing Bai
Francesca Zanderigo
Christine DeLorenzo
Jaya Prabhakaran
Ramin V. Parsey
J. John Mann
COX-2 selective inhibitors (COXIBs) are non-steroidal anti-inflammatory drugs (NSAIDs), with fewer side effects compared with non-selective NSAIDs, and are used for the treatment of arthritis, headaches, and other inflammatory diseases of the brain and peripheral tissues. Radiolabeled COXIBs may permit positron emission tomography (PET) imaging of COX-2 localization and activity in diseases, enable monitoring of inflammatory processes, and determine target occupancy of COX-2 activity by NSAIDs, thus, accelerating the development of novel CIXIBs. We synthesized [11C]celecoxib, one of the COXIBs and a prescription drug, and here report its in vivo uptake in the brain, whole body biodistribution, and radiation dosimetry in baboons using PET. Brain imaging experiments were performed in one baboon and whole body PET scans were performed in triplicates in two male baboons using an ECAT ACCEL (Siemens Medical Solutions, Inc. Knoxville) under anesthetic conditions. PET studies in baboons show that [11C]celecoxib penetrates the blood brain barrier (BBB) and accumulates in the brain, followed by a washout of radioactivity. The liver has the ...
Source: Molecules - Category: Chemistry Authors: J. S. Dileep Kumar Bing Bai Francesca Zanderigo Christine DeLorenzo Jaya Prabhakaran Ramin V. Parsey J. John Mann Tags: Article Source Type: research
More News: Anesthesia | Anesthesiology | Arthritis | Brain | Celebrex | Headache | Liver | Neurology | PET Scan | Rheumatology | Study | Urology & Nephrology